Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Prostate Adenocarcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Glandular Cell Neoplasm
Adenocarcinoma
Prostate Adenocarcinoma

Subtype

Prostate Adenocarcinoma

CI-CAN-00003766PRADExplore in graph →

133 active trials1 approved drugs3 evidence items

NCIt: C2919
OncoTree: PRAD
DOID: 2526
UMLS CUI: C0007112
Other

Overview
Statistics
Survival
Genomics26
Variants & evidence3
Drugs3
Trials433
Research
Rankings
Sources & provenance

1 more code

Clinical trials

Registered studies

433 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 62
Ph III recruiting: 5
Growth YoY: —
Industry share: 5%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (71)

StatusAll Active (any)Completed 181 Recruiting 71 Active Not Recruiting 69 Terminated 56 Unknown 25 Withdrawn 18 Not Yet Recruiting 6 Suspended 3 No Longer Available 3 Approved For Marketing 1

PhaseAll Early Phase 1 6 N/A 84 Phase 1 71 Phase 2 222 Phase 3 39 Phase 4 3

No study matches these filters